Overview of the inMIND Study

Panelists discuss the inMIND study, exploring the efficacy and safety of mindetuximab for the treatment of relapsed or refractory non-Hodgkin lymphoma and its potential impact on future therapeutic strategies.

EP: 1.Overview of the POLARIX Study

Now Viewing

EP: 2.Overview of the inMIND Study

EP: 3.Overview of the TRIANGLE Study

EP: 4.Overview of the ENRICH Study

Recent Videos